OR YEHUDA, Israel , November 28, 2016 /PRNewswire/ -- Valtech Cardio, Ltd., (Valtech), an innovator in the field of device development for mitral and tricuspid valve repair and replacement, today announced agreement to be acquired by Edwards Lifesciences Corporation (Edwards). The acquisition will give Edwards access to the CardiobandTM Reconstruction System (Cardioband) for transcatheter repair of the mitral valve and tricuspid valve of the heart. "We are pleased that Edwards, a global leader in patient focused medical innovations for structural heart disease, has elected to include in its growing portfolio of transcatheter based therapies, the CardiobandTM system for both mitral and tricus
OR YEHUDA, Israel , November 28, 2016 /PRNewswire/ -- Valtech Cardio, Ltd., (Valtech), an innovator in the field of device development for mitral and tricuspid valve repair and replacement, today announced agreement to be acquired by Edwards Lifesciences Corporation (Edwards). The acquisition will give Edwards access to the CardiobandTM Reconstruction System (Cardioband) for transcatheter repair of the mitral valve and tricuspid valve of the heart. "We are pleased that Edwards, a global leader in patient focused medical innovations for structural heart disease, has elected to include in its growing portfolio of transcatheter based therapies, the CardiobandTM system for both mitral and tricus
